These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 33098191)

  • 1. Impact of daily glucose fluctuations on cardiovascular outcomes after percutaneous coronary intervention for patients with stable coronary artery disease undergoing lipid-lowering therapy.
    Yamamoto H; Shinke T; Otake H; Kawamori H; Toba T; Kuroda M; Hirota Y; Sakaguchi K; Ogawa W; Hirata KI
    J Diabetes Investig; 2021 Jun; 12(6):1015-1024. PubMed ID: 33098191
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of daily glucose fluctuation on coronary plaque vulnerability in patients pre-treated with lipid-lowering therapy: a prospective observational study.
    Kuroda M; Shinke T; Sakaguchi K; Otake H; Takaya T; Hirota Y; Sugiyama D; Nakagawa M; Hariki H; Inoue T; Osue T; Taniguchi Y; Iwasaki M; Nishio R; Kinutani H; Konishi A; Hiranuma N; Takahashi H; Terashita D; Hirata KI
    JACC Cardiovasc Interv; 2015 May; 8(6):800-811. PubMed ID: 25999102
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association between daily glucose fluctuation and coronary plaque properties in patients receiving adequate lipid-lowering therapy assessed by continuous glucose monitoring and optical coherence tomography.
    Kuroda M; Shinke T; Sakaguchi K; Otake H; Takaya T; Hirota Y; Osue T; Kinutani H; Konishi A; Takahashi H; Terashita D; Uzu K; Hirata K
    Cardiovasc Diabetol; 2015 Jun; 14():78. PubMed ID: 26062762
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of the Mean Amplitude of Glycemic Excursions and Vascular Endothelial Dysfunction on Cardiovascular Events in Nondiabetic Patients With Coronary Artery Disease.
    Akasaka T; Sueta D; Tabata N; Takashio S; Yamamoto E; Izumiya Y; Tsujita K; Kojima S; Kaikita K; Matsui K; Hokimoto S
    J Am Heart Assoc; 2017 Apr; 6(5):. PubMed ID: 28446494
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnostic and prognostic value of a careful symptom evaluation and high sensitive troponin in patients with suspected stable angina pectoris without prior cardiovascular disease.
    Madsen DM; Diederichsen ACP; Hosbond SE; Gerke O; Mickley H
    Atherosclerosis; 2017 Mar; 258():131-137. PubMed ID: 28031149
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diurnal glycemic fluctuation is associated with severity of coronary artery disease in prediabetic patients: Possible role of nitrotyrosine and glyceraldehyde-derived advanced glycation end products.
    Watanabe M; Kawai Y; Kitayama M; Akao H; Motoyama A; Wakasa M; Saito R; Aoki H; Fujibayashi K; Tsuchiya T; Nakanishi H; Saito K; Takeuchi M; Kajinami K
    J Cardiol; 2017 Apr; 69(4):625-631. PubMed ID: 27470137
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term clinical outcomes in patients with untreated non-culprit intermediate coronary lesion and evaluation of predictors by using virtual histology-intravascular ultrasound; a prospective cohort study.
    Seo YH; Kim YK; Song IG; Kim KH; Kwon TG; Bae JH
    BMC Cardiovasc Disord; 2019 Aug; 19(1):187. PubMed ID: 31382885
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic Implication of Functional Incomplete Revascularization and Residual Functional SYNTAX Score in Patients With Coronary Artery Disease.
    Choi KH; Lee JM; Koo BK; Nam CW; Shin ES; Doh JH; Rhee TM; Hwang D; Park J; Zhang J; Kim KJ; Hu X; Wang J; Ye F; Chen S; Yang J; Chen J; Tanaka N; Yokoi H; Matsuo H; Takashima H; Shiono Y; Akasaka T
    JACC Cardiovasc Interv; 2018 Feb; 11(3):237-245. PubMed ID: 29361444
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship between LDL-C reduction after coronary revascularization and prevention of recurrence of cardiovascular events.
    Nishiwaki T; Kishi D; Yoshie F; Fukuda K; Ibuki C; Seino Y; Satoh M
    J Pharm Pharm Sci; 2010; 13(2):254-62. PubMed ID: 20816010
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glycemic Variability on Continuous Glucose Monitoring System Predicts Rapid Progression of Non-Culprit Lesions in Patients With Acute Coronary Syndrome.
    Kataoka S; Gohbara M; Iwahashi N; Sakamaki K; Nakachi T; Akiyama E; Maejima N; Tsukahara K; Hibi K; Kosuge M; Ebina T; Umemura S; Kimura K
    Circ J; 2015; 79(10):2246-54. PubMed ID: 26227393
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of glycemic variability and the presence and severity of coronary artery disease in patients with type 2 diabetes.
    Su G; Mi S; Tao H; Li Z; Yang H; Zheng H; Zhou Y; Ma C
    Cardiovasc Diabetol; 2011 Feb; 10():19. PubMed ID: 21349201
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Does proximal location of culprit lesion confer worse prognosis in patients undergoing primary percutaneous coronary intervention for ST elevation myocardial infarction?
    Harjai KJ; Mehta RH; Stone GW; Boura JA; Grines L; Brodie BR; Cox DA; O'Neill WW; Grines CL;
    J Interv Cardiol; 2006 Aug; 19(4):285-94. PubMed ID: 16881971
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The assessment of non culprit coronary artery lesions in patients with ST segment elevated myocardial infarction and multivessel disease by control angiography with quantitative coronary angiography.
    Dönmez E; Koç M; Şeker T; İçen YK; Çayli M
    Int J Cardiovasc Imaging; 2016 Oct; 32(10):1471-6. PubMed ID: 27448213
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The natural course of nonculprit coronary artery lesions; analysis by serial quantitative coronary angiography.
    Kang J; Park KW; Lee MS; Zheng C; Han JK; Yang HM; Kang HJ; Koo BK; Kim HS
    BMC Cardiovasc Disord; 2018 Jun; 18(1):130. PubMed ID: 29954346
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design and rationale of the COMPLETE trial: A randomized, comparative effectiveness study of complete versus culprit-only percutaneous coronary intervention to treat multivessel coronary artery disease in patients presenting with ST-segment elevation myocardial infarction.
    Mehta SR; Wood DA; Meeks B; Storey RF; Mehran R; Bainey KR; Nguyen H; Bangdiwala SI; Cairns JA;
    Am Heart J; 2019 Sep; 215():157-166. PubMed ID: 31326681
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of CD14
    Yamamoto H; Yoshida N; Shinke T; Otake H; Kuroda M; Sakaguchi K; Hirota Y; Toba T; Takahashi H; Terashita D; Uzu K; Tahara N; Shinkura Y; Kuroda K; Nagasawa Y; Nagano Y; Tsukiyama Y; Yanaka KI; Emoto T; Sasaki N; Yamashita T; Ogawa W; Hirata KI
    Atherosclerosis; 2018 Feb; 269():245-251. PubMed ID: 29407600
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ischemia change in stable coronary artery disease is an independent predictor of death and myocardial infarction.
    Farzaneh-Far A; Phillips HR; Shaw LK; Starr AZ; Fiuzat M; O'Connor CM; Sastry A; Shaw LJ; Borges-Neto S
    JACC Cardiovasc Imaging; 2012 Jul; 5(7):715-24. PubMed ID: 22789940
    [TBL] [Abstract][Full Text] [Related]  

  • 18. B-Type Natriuretic Peptide Assessment in Patients Undergoing Revascularization for Left Main Coronary Artery Disease: Analysis From the EXCEL Trial.
    Redfors B; Chen S; Crowley A; Ben-Yehuda O; Gersh BJ; Lembo NJ; Brown WM; Banning AP; Taggart DP; Serruys PW; Kappetein AP; Sabik JF; Stone GW
    Circulation; 2018 Jul; 138(5):469-478. PubMed ID: 29666071
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Global coronary flow reserve is associated with adverse cardiovascular events independently of luminal angiographic severity and modifies the effect of early revascularization.
    Taqueti VR; Hachamovitch R; Murthy VL; Naya M; Foster CR; Hainer J; Dorbala S; Blankstein R; Di Carli MF
    Circulation; 2015 Jan; 131(1):19-27. PubMed ID: 25400060
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The impact of vildagliptin on the daily glucose profile and coronary plaque stability in impaired glucose tolerance patients with coronary artery disease: VOGUE-A multicenter randomized controlled trial.
    Yamamoto H; Konishi A; Shinke T; Otake H; Kuroda M; Osue T; Sawada T; Takaya T; Kawai H; Hashimoto N; Ohara T; Hirota Y; Sakaguchi K; Omori T; Ogawa W; Hirata KI
    BMC Cardiovasc Disord; 2021 Feb; 21(1):92. PubMed ID: 33588758
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.